Ribosomal protein L17 pseudogene 13 (RPL17P13)

Ribosomal protein L17 pseudogene 13 (RPL17P13) is classified as a processed pseudogene and is a non-functional copy of the gene encoding the ribosomal protein L17[1][5][2]. Pseudogenes such as RPL17P13 arise from retrotransposition events, resulting in DNA sequences similar to functional genes but generally unable to produce functional proteins due to accumulated mutations or premature stop codons[2]. The parent gene, RPL17, encodes a component of the 60S ribosomal subunit, but RPL17P13 itself is not transcribed into a functional protein and has no characterized role in cell biology, disease, or therapy[1][5][2]. Pseudogenes are sometimes mistakenly annotated as real genes because of their high sequence similarity to their parent genes; however, the consensus is that RPL17P13, like most ribosomal pseudogenes, is non-functional[2][1][5]. Key Points: - RPL17P13 is a processed pseudogene and not a functional protein or therapeutic target. - It has no direct biological activity, disease relevance, or pharmacological significance. - Pseudogenes like RPL17P13 serve primarily as evolutionary relics, though rarely they may have regulatory RNA roles; no such function is reported for RPL17P13[2][1].

Other names

RPL17_7_285RPL17P13